BN Business News
Add your company to Business Communicator →

Business · 01/06/2026

FDA Announces Draft Guidance for Streamlined Nonclinical Safety Studies for Oncology Pharmaceuticals

The FDA is releasing a draft guidance to help pharmaceutical companies develop cancer treatments with reduced animal testing, building on lessons learned during the COVID-19 pandemic.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights